Clinical trial
Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid…
NCT00452543 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00452543 |
|---|---|
| Title | Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism |
| Official title | A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) With Comorbid Alcohol Abuse/Dependence |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Alcohol Abuse, Alcohol Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | acamprosate, escitalopram, Medical management, Placebo |
| Enrollment | 23 |
| Start date | Mar 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 27, 2007 |
| Last update posted | Jul 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: